innovations, including precision drugs, diagnostics, treatments, clinical guidelines, and digital health technologies (DHTs). Department/Directorate Information The Cancer Research UK Convergence Science Centre (CSC) is a partnership between Imperial College London and The Institute of Cancer Research (ICR) with funding from Cancer Research UK. Convergence research is driven by a societal need and utilises a deep integration across disciplines. Professor Axel Behrens is the Scientific Director of the CRUK Convergence Science Centre. This position of Health Economist is integrated within our Cancer Technology Catalyst team (CTC). The CTC is an initiative designed to expedite the journey of promising cancer technologies from concept to clinical impact. Led by a diverse team of experts, the CTC is committed to unlocking the full potential of innovative solutions and addressing the challenges inherent in bringing them to patients. By harnessing a collaborative Team Science approach, the CTC works closely with Principal Investigators and their teams to develop comprehensive evidence packages that not only inform robust value propositions for cancer technologies, but also strategically position them for successful clinical integration. About you Please see the attached job description for essential skills and qualifications for this role, and further information. What we offer A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Patrick Kierkegaard via p.kierkegaard@imperial.ac.uk .

innovations, including precision drugs, diagnostics, treatments, clinical guidelines, and digital health technologies (DHTs). Department/Directorate Information The Cancer Research UK Convergence Science Centre (CSC) is a partnership between Imperial College London and The Institute of Cancer Research (ICR) with funding from Cancer Research UK. Convergence research is driven by a societal need and utilises a deep integration across disciplines. Professor Axel Behrens is the Scientific Director of the CRUK Convergence Science Centre. This position of Health Economist is integrated within our Cancer Technology Catalyst team (CTC). The CTC is an initiative designed to expedite the journey of promising cancer technologies from concept to clinical impact. Led by a diverse team of experts, the CTC is committed to unlocking the full potential of innovative solutions and addressing the challenges inherent in bringing them to patients. By harnessing a collaborative Team Science approach, the CTC works closely with Principal Investigators and their teams to develop comprehensive evidence packages that not only inform robust value propositions for cancer technologies, but also strategically position them for successful clinical integration. About you Please see the attached job description for essential skills and qualifications for this role, and further information. What we offer A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Patrick Kierkegaard via p.kierkegaard@imperial.ac.uk .